Latest in News & Research

Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment

Remibrutinib results in significant improvement in composite measure of itching and hives at week 12 after second-generation H1-antihistamine treatment

By Elana Gotkine (HealthDay News) | | March 11, 2025

Tax-Loss Harvesting as a Strategy for Tax-Efficient Investing: A Physician’s New Friend

In this recurring column, Dermsquared and J.P. Morgan provide tailored financial strategies and investment insights for the dermatology community. Each 500-word article highlights key...

By Ethan Emma, Managing Director, J.P. Morgan Wealth Management | | March 10, 2025

Risk for Lymphoma, Skin Cancer Increased in Individuals With Tattoos

Increased risks seen based on twin cohort and case-cotwin studies

By Elana Gotkine (HealthDay News) | | March 07, 2025

At-Home Light-Emitting Diode Devices Safe, Effective for Acne Treatment

Review finds red, blue, and combination wavelength devices are all effective

By Lori Solomon (HealthDay News) | | March 06, 2025

Biosimilars Amjevita and Imraldi as Effective as Humira for Psoriasis

Amjetiva and Imradi as effective as Humira for new users and in switcher analysis

By Dermsquared Editorial Team | | March 05, 2025

Handheld Reflectance Confocal Microscopy Efficacious for Detecting Lentigo Maligna (Melanoma)

HH-RCM can precisely identify surgical margins and is associated with a reduction in recurrence rates of lentigo maligna (melanoma)

By Dermsquared Editorial Team | | March 05, 2025

Lead, Toxic Chemicals Found in Synthetic Braiding Hair

TUESDAY, March 4, 2025 -- Some popular synthetic hair products used for braids, twists and extensions may contain cancer-causing chemicals and high levels of...

By I. Edwards (HealthDay News) | | March 04, 2025

Real-World Study Shows Effectiveness of Ixekizumab for Psoriasis

Significant clinical improvements seen with and without induction therapy, with faster initial response with induction

By Elana Gotkine (HealthDay News) | | February 28, 2025

One in Six Parents Support Teens Getting Nonsurgical Cosmetic Procedures

However, less than half of parents support procedures even for mental health or bullying concerns

By Lori Solomon (HealthDay News) | | February 28, 2025

Children With Obesity Have Increased Rates of Dermatologic Conditions

Children with obesity and specific comorbidities, including HTN and T2D, have increased risk for almost every skin condition

By Elana Gotkine (HealthDay News) | | February 26, 2025

Dermatomyositis, Clinically Amyopathic Dermatomyositis Often Misdiagnosed

Misdiagnosis rates higher for the clinically amyopathic DM cohort versus DM cohort, with longer median diagnostic delays

By Dermsquared Editorial Team | | February 26, 2025

Mohs Surgery Best for Local Recurrence in Anogenital Squamous Cell Carcinoma

Local recurrence rates lower compared with wide local excision, but no difference seen in regional, distant recurrence

By Dermsquared Editorial Team | | February 26, 2025

Benzoyl Peroxide Formulation Characteristics Explain Variation in Benzene Levels

Leave-on products linked to lower concentrations of benzene; increased concentrations seen in conditions consistent with hot processing

By Elana Gotkine (HealthDay News) | | February 19, 2025

Mohs Surgery Linked to Improved Outcomes for Primary High-Stage cSCC

Improved outcomes seen in local recurrence, nodal metastasis, distant metastasis, any recurrence, disease-specific death

By Dernsquared Editorial Team | | February 19, 2025

Intralesional Immunotherapy Promising for Molluscum Contagiosum

Intralesional immunotherapy with candida antigen and varicella zoster vaccine effective, seems safe

By Dermsquared Editorial Team | | February 19, 2025

Sleep, Psychological Disorders More Prevalent With Pediatric Inflammatory Skin Disease

Risks increased for hypersomnia, sleep apnea, fatigue, and depression for children with psoriasis

By Dermsquared Editorial Team | | February 12, 2025

Immune Checkpoint Inhibitors Appear to Reduce Actinic Keratoses

Reduction seen in keratinocyte carcinoma total numbers from 42 to 17 in 12 months before versus after starting ICI therapy

By Dermsquared Editorial Team | | February 12, 2025

Tax-Aware Borrowing: Strategies for Minimizing Tax Liability: 500 Words to Sharpen Your Strategy

In this recurring column, Your Finances in Focus: 500 Words to Sharpen Your Strategy, Dermsquared and J.P. Morgan provide tailored financial strategies and investment...

By Ethan Emma, Managing Director, J.P. Morgan Wealth Management | | February 11, 2025

New Facial Plastic Surgery Survey Illustrates Impact of GLP-1 Receptor Agonists

GLP-1 receptor agonists driving growing demand for nonsurgical treatments to address 'Ozempic face'

By Lori Solomon (HealthDay News) | | February 07, 2025

Early Childhood Stressful Life Events Linked to Increased Eczema Activity

Association driven by common stressful life events such as starting new school, having new baby sibling

By Elana Gotkine (HealthDay News) | | February 05, 2025

Risk for Skin Cancers Higher for Patients With Hematologic Malignancies

Increased risks seen for cutaneous squamous cell carcinoma, malignant melanoma, Merkel cell carcinoma, basal cell carcinoma

By Dermsquared Editorial Team | | February 05, 2025

Haptic Feedback Can Reduce Nocturnal Scratching in Mild Eczema

Significant decrease seen in mean scratch events nightly and in mean scratch duration per hour of sleep opportunity

By Dermsquared Editorial Team | | February 05, 2025

Ritlecitinib-Induced Hair Regrowth at 24 Weeks Sustained Through 48 Weeks

≥85 and ≥68 percent of patients with Severity of Alopecia Tool score ≤20 and ≤10 responses at week 24 sustained these responses

By Dermsquared Editorial Team | | January 29, 2025

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026